Edition:
United Kingdom

Quidel Corp (QDEL.OQ)

QDEL.OQ on NASDAQ Stock Exchange Global Select Market

40.17USD
13 Dec 2017
Change (% chg)

$0.16 (+0.40%)
Prev Close
$40.01
Open
$40.11
Day's High
$40.27
Day's Low
$39.68
Volume
67,598
Avg. Vol
130,654
52-wk High
$45.49
52-wk Low
$18.25

Latest Key Developments (Source: Significant Developments)

Quidel Says Confident In Validity Of Supply Agreement With Beckman Coulter To Sell BNP Assay Assets
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Quidel Corp ::QUIDEL CONFIDENT IN LEGAL STRENGTH AND VALIDITY OF SUPPLY AGREEMENT WITH BECKMAN COULTER TO SELL BNP ASSAY ASSETS.CO ‍ACKNOWLEDGED BECKMAN COULTER PLANS TO PURSUE COMMERCIAL LITIGATION TO ALLOW IT TO SELL BNP DIRECTLY.‍IN RECENT WEEKS, BOARD REJECTED OFFERS BY DANAHER CORP TO BUY BNP ASSAY BUSINESS​.‍BOARD FOUND THAT DANAHER'S PROPOSAL WAS "INADEQUATE" FOR BNP ASSAY BUSINESS​.  Full Article

Quidel Corp reports Q3 GAAP loss per share $0.16
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Quidel Corp ::Quidel reports third quarter 2017 financial results.Q3 gaap loss per share $0.16.Q3 revenue $50.9 million versus I/B/E/S view $50.3 million.Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S.Q3 non-gaap earnings per share $0.17.  Full Article

Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Quidel Corp :Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA.Quidel - ‍Sofia Lyme FIA is for detecting human antibodies to Borrelia burgdorferi from serum & plasma specimens from patients with B. burgdorferi infection​.  Full Article

Quidel gets FDA nod for Solana Assay molecular diagnostic test
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Quidel Corp :Quidel receives FDA clearance for its Solana RSV + hMPV Assay.Quidel corp - ‍received clearance from U.S. FDA to market its solanarespiratory syncytial virus + human metapneumovirus assay​.  Full Article

Quidel Corp says ‍on Oct 6, co entered into credit agreement​
Friday, 6 Oct 2017 

Oct 6 (Reuters) - Quidel Corp :Quidel corp says ‍on Oct 6, co entered into credit agreement​ - sec filing.Quidel - ‍credit agreement provided co with $245.0 million senior secured term loan facility, $25.0 million revolving credit facility​.Quidel Corp - ‍credit agreement includes an accordion feature that allows financing to be increased by $50 million upon satisfaction of certain conditions​.  Full Article

Quidel receives FDA clearance for Solana Influenza A+B Assay
Tuesday, 27 Sep 2016 

Quidel Corp : Quidel receives FDA clearance for its Solana(R) Influenza A+B assay in time for the upcoming 2016-2017 flu season .Received 510(k) clearance from United States Food and Drug Administration (FDA) to market its Solana Influenza A+B assay.  Full Article

Quidel gets FDA clearance for Solana Trichomonas assay
Wednesday, 17 Aug 2016 

Quidel Corp : Quidel receives FDA clearance for its Solana Trichomonas assay for diagnosis of trichomoniasis .Has received clearance from United States Food and Drug Administration to market its Solana Trichomonas assay.  Full Article

Quidel Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S
Wednesday, 27 Jul 2016 

Quidel Corp : Quidel reports second quarter 2016 financial results . Q2 Non-GAAP loss per share $0.11 . Q2 GAAP loss per share $0.24 . Q2 revenue $39.1 million versus I/B/E/S view $38 million .Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Quidel Says Confident In Validity Of Supply Agreement With Beckman Coulter To Sell BNP Assay Assets

* QUIDEL CONFIDENT IN LEGAL STRENGTH AND VALIDITY OF SUPPLY AGREEMENT WITH BECKMAN COULTER TO SELL BNP ASSAY ASSETS